EDGAR Filing Documents for 0001104659-15-054344

Form 8-K - Current report:

SEC Accession No. 0001104659-15-054344

Filing Date

2015-07-29

Accepted

2015-07-29 16:30:27

Documents

Period of Report

2015-07-29

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-16529_38k.htm	8-K	25334
2	EX-99.1	a15-16529_3ex99d1.htm	EX-99.1	19030
3	GRAPHIC	g165293mmi001.jpg	GRAPHIC	10293
	Complete submission text file	0001104659-15-054344.txt		60089

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034

Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000

Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 151013129
SIC: 2834 Pharmaceutical Preparations